The HiLo trial: a multicentre randomised trial of high- versus low-dose radioiodine, with or without recombinant human thyroid stimulating hormone, for remnant ablation after surgery for differentiated thyroid cancer - Mallick, U; Harmer, C; Hackshaw, A (Clin Oncol (R Coll Radiol), 2008)